Beyond biopharma innovators, other types of players, such as telehealth and digital health companies, have also been attracted by the obesity opportunity, for example, offering prescription services for anti-obesity drugs as part of comprehensive weight loss or disease management programmes for chronic conditions, which typically include counselling on behavioural, nutrition and activity changes with the aim to achieve lasting weight reduction 11
Working with a care team that includes a dietitian, behavioral counselor, and healthcare provider can set you up for long-term success
If it's not the right fit, you can request a full refund within 30 days
Noom is rolling out two new solutions that aim to make it easier for employers and members to manage GLP-1s, and it's teaming up with Waltz Health to power one of the offerings
Key Takeaways In a 2025 study, roughly 10% weight loss on a GLP-1 drug raised the share of men with normal total and free testosterone from 53% to 77% with no hormone therapy given
doi: 10.3920/bm2016.0207 108
